A carregar...
Inhibition of PIM2 in liver cancer decreases tumor cell proliferation in vitro and in vivo primarily through the modulation of cell cycle progression
Liver cancer is the fourth leading cause of cancer-related mortality worldwide with limited therapeutic options. Thus, novel treatment strategies are urgently required. While the oncogenic kinase, proviral integration site for Moloney murine leukemia virus 2 (PIM2), has been shown to be overexpresse...
Na minha lista:
| Publicado no: | Int J Oncol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6959465/ https://ncbi.nlm.nih.gov/pubmed/31894300 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2019.4936 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|